Curis Lifesciences IPO Lists at ₹146.10 on NSE Emerge With a Premium of 14.14% Above Issue Price

Ahmedabad, November 14: Curis Lifesciences IPO listed today on NSE Emerge with a 14.14% premium over the issue price. The Curis Lifesciences shares listed at ₹146.10, above their issue price of ₹128 per share. As of 12:40 PM, Curis Lifesciences’ share price was up by 12.59%, or 17.40 points, and was trading at ₹145.40. Until now, the Curis Lifesciences shares have traded within a range of ₹147.90 and ₹138.80. The traded volume stood at 10.39 lakh shares.

Curis Lifesciences Limited (NSE EMERGE: CURIS) is a pharmaceutical manufacturing company that produces a wide range of pharmaceutical products. Its portfolio includes tablets, capsules, oral liquids, external preparations (like creams and gels), and sterile ophthalmic ointments. The company was established in 2010 and is headquartered in Ahmedabad, Gujarat.

Curis Lifesciences IPO: Anchor Allocation

Ahead of the public issue, Curis Lifesciences raised ₹7.79 crore through its anchor book on November 6 by allocating 6,09,000 equity shares at ₹128 each to six institutional investors, namely Sanshi Fund-I, Maiq Growth Scheme–Long Only, Strategic Sixth Sense Capital Fund, Viney Growth Fund, Zeta Global Funds (OEIC) PCC Ltd – Zeta Series A Fund PC, and Moneywise Financial Services Pvt. Ltd.

Curis Lifesciences IPO Subscription Status

The Curis Lifesciences IPO received strong investor interest, with an overall subscription status of 74.39 times. Non-Institutional Investors (NIIs) led the charge, subscribing 115.46 times, followed by Qualified Institutional Buyers (QIBs) at 96.17 times, and retail investors at 44.28 times.

Investor Takeaway

Curis Lifesciences IPO has listed on NSE EMERGE at ₹146.10, above its issue price of ₹128, reflecting a 14.14% listing gain. The shares have seen significant trading activity, moving between ₹138.80 and ₹147.90 so far. Investors will monitor the stock closely in the coming days for further price movements.

REF: https://www.nseindia.com/get-quotes/equity?symbol=CURIS

Disclaimer: At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur.

If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.

Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations